|
Swamy seeks resignation of HR & CE Minister
(Cached)
|
18.3.2010 |
Hindu: Tamil Nadu |
| |
|
Also found in:
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[sandman1965 :: Realty]
[ssurekha :: news]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: everywhere]
|
|
Latha Jishnu: Let's hear it for Brazil
|
18.3.2010 |
Business Standard: Economy & Policy |
| At a recent UNDP consultation on access to affordable medicines, I was struck by the presentation made by Juliana Borges Vallini, a young woman from Brazil. Vallini is head of intellectual property (IP) for the Ministry of Healths programme on HIV/AIDS and hepatitis, and her job is to ensure that the ministry has access to the most affordable drugs needed to treat Brazilians suffering from either of these conditions. Health is a fundamental right in Brazil and the country guarantees universal access to treatment. In 2008, it spent as much as $640 million just for treating its 190,000 AIDS patients. |
|
Also found in:
[fredericknoronha :: UNDP]
[phemk23 :: Northern Plains]
[nwct :: Healthcare]
[esg :: Water-borne]
[esg :: HIV]
[ajnyani :: AGECON]
[fredericknoronha :: music]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
|
|
Qualcomm to line up for broadband wireless
(Cached)
|
18.3.2010 |
Financial Express: Front Page |
| CDMA technology patent holder Qualcomm on Wednesday said it would bid for one of the two slots of the spectrum in the upcoming broadband wireless auction. The San Diego-based company has already participated in such an auction in the US and the UK. |
|
Also found in:
[vishwas :: india]
[vishwas :: everywhere]
[vj712 :: Indian startups]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[sandman1965 :: Telecom]
[sandman1965 :: Spectrum]
[sandman1965 :: Broadband]
[fredericknoronha :: mobile phone]
[TahirAmin :: everywhere]
[ind32 :: Indian startups]
|
|
‘Delay in getting patents in India eroding technologies'
(Cached)
|
17.3.2010 |
Hindu: Kerala |
| |
|
Also found in:
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[fredericknoronha :: Kerala]
|
|
AstraZeneca says will be picky in emerging markets
|
16.3.2010 |
Business Standard: News Now |
| AstraZeneca expects double-digit growth in emerging markets, the new battleground for Big Pharma as sales in Western markets stall, but said today that it would be much more selective than some of its rivals. |
|
Also found in:
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
|
|
Patent dispute resolution, a booster for Ranbaxy
|
16.3.2010 |
Business Standard: News Now |
| Ranbaxy Laboratories has firmed up aftersettlinga patent dispute with Takeda Pharmaceutical Company regarding a generic version of the Japanese companys diabetes drug, Actos, in the United States. Indias leading drug maker by sale is trading at the day's high of Rs 473, stronger by Rs 7 or 1.7%, on the BSE. The shares had opened at Rs 470 and have touched a low of Rs 467 thus far. |
|
Also found in:
[esg :: All]
[esg :: Diabetes]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
|
|
Ranbaxy and Takeda settle patent row
(Cached)
|
16.3.2010 |
TOI: India Business |
| Ranbaxy Laboratories Ltd settled a patent dispute with Takeda Pharmaceutical Co allowing the Indian drugmaker to sell a generic version of Actos, the world’s biggest selling diabetes medicine, in the US. |
|
Also found in:
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[esg :: All]
[esg :: Diabetes]
|
|
Ranbaxy, Takeda settle Actos patent dispute
|
16.3.2010 |
Business Standard: Companies & Industry |
| Ranbaxy Laboratories Ltd, Indias leading drug maker by sale, today said it had settled with Takeda Pharmaceutical Company Ltd a patent dispute related to a generic version of the Japanese companys diabetes drug, Actos, in the United States. |
|
Also found in:
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[esg :: All]
[esg :: Diabetes]
|
|
Kiri Dyes buys DyStar of Germany for Rs 310 cr
(Cached)
|
16.3.2010 |
HBL: Corporate |
| Ahmedabad-based Kiri Dyes and Chemicals (KDCL) has acquired DyStar of Germany for €50 million (Rs 310 |
|
Also found in:
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[sandman1965 :: Deals]
|
|
Ranbaxy settles drug dispute with Takeda, US launch in 2012
(Cached)
|
15.3.2010 |
Hindustan Times: Business |
| Ranbaxy Laboratories Ltd today said it has entered into an agreement with the Japanese drug maker Takeda Pharmaceuticals for ending the patent litigation regarding diabetic drug Actos. |
|
Also found in:
[esg :: All]
[esg :: Diabetes]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
|
|
Venus Remedies gets patent for Sulbactomax
(Cached)
|
15.3.2010 |
HBL: Breaking News |
| Venus Remedies gets patent for Sulbactomax |
|
Also found in:
[sandman1965 :: Realty]
[vj712 :: Indian startups]
[ind32 :: Indian startups]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[fredericknoronha :: Copyright]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
|
|
Ranbaxy settles Actos patent litigation
|
15.3.2010 |
Business Standard: News Now |
| Ranbaxy Laboratories today said that it has settled its Actos patent litigation with Japan's Takeda Pharmaceutical company. |
|
Also found in:
[sailendram :: Market]
[fredericknoronha :: japan]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[shrimali :: contract farming]
[esg :: All]
[esg :: Diabetes]
|
|
United Phos has a generic advantage in agri play
(Cached)
|
15.3.2010 |
DNA: Top News |
| United Phosphorus Ltd (UPL), a global generic crop protection, chemicals and seeds company, is a good play on the agricultural growth story. |
|
Also found in:
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[TahirAmin :: everywhere]
[vj712 :: Indian startups]
[ajnyani :: AGECON]
[ind32 :: Indian startups]
[vishwas :: india]
[vishwas :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
|
|
Grand culture of India backbone of cultpture, says artist
|
15.3.2010 |
Deccan Herald: District |
| Grand culture of India backbone of cultpture, says artist |
|
Also found in:
[TahirAmin :: everywhere]
[subbu :: All News]
|
|
Patent Cell at PEC proposed
(Cached)
|
14.3.2010 |
Hindu: Other States |
| |
|
Also found in:
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[sandman1965 :: Realty]
[meerak :: bengaluru]
[meerak :: bengaluru civic]
[meerak :: bengaluru government]
[meerak :: bengaluru business]
|
|
‘IP regime is one sided'
(Cached)
|
13.3.2010 |
Hindu: Karnataka |
| |
|
Also found in:
[ssurekha :: news]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[sandman1965 :: Realty]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[fredericknoronha :: Kerala]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[fredericknoronha :: Copyright]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: everywhere]
|
|
Panacea eyes generics, US operations
(Cached)
|
13.3.2010 |
DNA: Top News |
| May offer products in hypertension, type 2 diabetes and gastrointestinal disease space. |
|
Also found in:
[ind32 :: Indian startups]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[esg :: All]
[esg :: All]
[esg :: Diabetes]
[esg :: Lifestyle]
[vj712 :: Indian startups]
|
|
Patent cell at PEC proposed
(Cached)
|
13.3.2010 |
Hindu: Other States |
| |
|
Also found in:
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[sandman1965 :: Realty]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[meerak :: bengaluru]
[meerak :: bengaluru civic]
[meerak :: bengaluru government]
[meerak :: bengaluru business]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
|
|
Protect the drug giants' patents - and harm the health of the poor?
|
13.3.2010 |
The Guardian -- World Latest |
| India has become "the pharmacy of the world", home to dozens of generic copycat drug companies that have been producing expensive medicines at dirt-cheap prices that the poorest countries can afford. Famously, Mumbai-based Cipla forced down the prices of Aids drugs some years ago with the launch of a twice a day pill, which then became the staple treatment in many sub-Saharan countries.
But Medecins sans Frontieres , also known as Doctors without Borders, which played a role in that epic turnaround, is now warning that a Free Trade Agreement between the EU and India could ensure that sort of Robin Hood episode never happens again. Yesterday, its supporters demonstrated in New Delhi. They fear the EU, negotiating behind closed doors, will push ... |
|
Also found in:
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[prashantiyengar :: india]
[prashantiyengar :: everywhere]
[TOM :: All-States]
[sandman1965 :: Realty]
[newstrust :: Access]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[vishwas :: india]
[vishwas :: everywhere]
[rakujha :: social-defence]
[pwdc :: All-States]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
[newstrust :: India and Global Economy]
[newstrust :: Trade]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
[Genecampaign :: india]
[Genecampaign :: everywhere]
|
|
AstraZeneca ties up with Indian drugmaker
|
12.3.2010 |
Financial Times India: Business |
| The alliance with Torrent Pharmaceuticals is the first step in the Anglo-Swedish pharmaceutical group's plans to rapidly expand sales of generic drugs |
|
Also found in:
[vj712 :: Indian startups]
[fredericknoronha :: Copyright]
[ind32 :: Indian startups]
[TahirAmin :: everywhere]
[TahirAmin :: india]
[TahirAmin :: everywhere]
|
